This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) inched 0.61% higher to $661.14 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.01% to 3,901.36 and the Dow Jones Industrial Average rising 0.03% to 31,261.90. The stock's rise snapped a two-day losing streak. Regeneron Pharmaceuticals Inc. closed $86.28 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) rose 1.75% to $176.98, Novartis AG ADR (NOVN.EB) rose 0.87% to $89.42, and Amgen Inc. (AMGN) rose 1.12% to $247.50. Trading volume (544,226) remained 123,540 below its 50-day average volume of 667,766.
Data source: Dow Jones Market Data, FactSet. Data compiled May 20, 2022.
(END) Dow Jones Newswires
May 20, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.